TRIM44 and thyroid gland papillary carcinoma: Zhou Z and others found that TRIM44 is highly expressed in human papillary thyroid carcinoma and increases the proliferation and invasion of papillary thyroid cancer cells by activating the Wnt/β-catenin signaling pathway (Zhou et al., 2017).